Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV: experience in a pediatric population

Background Although dual-boosted protease inhibitors regimen is not recommended in children with HIV infection, such a strategy could be useful in subjects with a complex resistance profile. This study was aimed at assessing the long term efficacy and safety of a double-boosted protease inhibitor co...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	BMC infectious diseases Ročník 12; číslo 1; s. 179
Hlavní autoři:	Rusconi, Stefano, Giacomet, Vania, Mameli, Chiara, Viganò, Alessandra, Viganò, Ottavia, Adorni, Fulvio, Galli, Massimo, Zuccotti, Gian Vincenzo
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BioMed Central 06.08.2012 BioMed Central Ltd Springer Nature B.V BMC
Témata:	Adolescent Adolescents Anti-HIV Agents - administration & dosage Antiretroviral agents Antiretroviral drugs Antiretroviral Therapy, Highly Active - methods Atazanavir Atazanavir Sulfate Bilirubin Blood cholesterol Carbamates - administration & dosage Care and treatment CD4 Lymphocyte Count Child Children Cholesterol DNA polymerases Dosage and administration Drug therapy Female Fosamprenavir Highly active antiretroviral therapy HIV HIV (Viruses) HIV and co-infections HIV infection HIV Infections - drug therapy HIV Protease Inhibitors - administration & dosage Human immunodeficiency virus Humans Hypercholesterolemia Infection Infectious Diseases Insulin resistance Internal Medicine Lipids - blood Male Medical Microbiology Medical research Medicine Medicine & Public Health Medicine, Experimental Mutation Nucleosides Oligopeptides - administration & dosage Organophosphates - administration & dosage Parasitology Pediatrics Protease inhibitors Proteases Proteinase inhibitors Pyridines - administration & dosage Research Article Ritonavir Ritonavir - administration & dosage RNA RNA, Viral - blood Salvage Therapy - methods Sulfonamides - administration & dosage Treatment Outcome Tropical Medicine Viral Load Italy Atazanavir Darunavir Ritonavir Nucleoside Reverse Transcriptase Inhibitor Virological Failure
ISSN:	1471-2334, 1471-2334
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!